reports
Liquidia Corporation to Report Full Year 2025 Financial Results on Mar...
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 MORRISVILLE, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that it will report its full year 2025 financial results on Thursday, March 5, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The webcast will be available on Liquidia’s website at . A rebroadcast of the ev...
Noodles & Company to Announce Fourth Quarter and Full Year 2025 Result...
Noodles & Company to Announce Fourth Quarter and Full Year 2025 Results on March 25, 2026 BROOMFIELD, Colo., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) today announced that it will host a conference call to discuss its fourth quarter and full year 2025 financial results on Wednesday, March 25, 2026, at 4:30 p.m. ET. Joe Christina, Chief Executive Officer, and Mike Hynes, Chief Financial Officer, will host the call. A press release with fourth quarter and full year 2025 financial results will be issued after the market close that same day. The conference call can b...
Donegal Group Inc. Announces Fourth Quarter and Full Year 2025 Results
Donegal Group Inc. Announces Fourth Quarter and Full Year 2025 Results MARIETTA, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) today reported its financial results for the fourth quarter and full year ended December 31, 2025. Significant items for fourth quarter of 2025 (all comparisons to fourth quarter of 2024): Net premiums earned decreased 4.1% to $226.9 millionCombined ratio of 96.3%, compared to 92.9%Net income of $17.2 million, or 47 cents per diluted Class A share, compared to $24.0 million, or 70 cents per diluted Class A shareNet i...
Noodles & Company Announces Plans For 1-for-8 Reverse Stock Split Effe...
Noodles & Company Announces Plans For 1-for-8 Reverse Stock Split Effective February 18, 2026 BROOMFIELD, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) announced today that it plans to effect a 1-for-8 reverse stock split ("Reverse Stock Split") of its Class A common stock, par value $0.01 per share ("Common Stock"), that is expected to become effective on February 18, 2026 at 12:01 a.m.. Eastern Time. Noodles’ Common Stock will continue to trade on The Nasdaq Global Select Market (“Nasdaq”) under the existing symbol “NDLS” and is expected to begin trading on ...
Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-...
Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2025 Results MARIETTA, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for fourth quarter and full year ended December 31, 2025, on Thursday, February 19, 2026, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at , concurrently with its earnings press release. At approximately 8:30 am ET on Thursday, F...
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonar...
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today the company will present three posters at the Pulmonary Vascular Research Institute (PVRI) 2026 Annual Congress to be held January 28 through February 1, 2026, in Dublin, Ireland. The presentations highlight clinical data in pulmonary arterial hypertensi...
Noodles & Company Announces Preliminary Revenue Results for the Fourth...
Noodles & Company Announces Preliminary Revenue Results for the Fourth Quarter of 2025 Company to Host Investor Meetings at 28th Annual ICR Conference BROOMFIELD, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) today released preliminary, unaudited sales results for the fourth fiscal quarter ended December 30, 2025. Preliminary Fourth Quarter of 2025 Sales Results Compared to the Fourth Quarter of 20241: Fourth quarter system-wide comparable sales increased 6.6%, comprised of a 7.3% increase at company-owned restaurants and a 3.8% increase at franchise restau...
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net...
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in June 2025Generated more than $30 million of positive cash flow during the fourth quarter 2025 MORRISVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging ...
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare ...
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 beginning at approximately 5:15 p.m. Pacific Time (8:15 p.m. Eastern Time) at the Westin St. Francis in San Francisco, California. Access to a live, audio-only webcast will be available on the “Investors” page of Liquidia’s website at . The webcast will be archive...
Donegal Group Inc. Announces Quarterly Dividend
Donegal Group Inc. Announces Quarterly Dividend MARIETTA, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) reported today that its board of directors declared a regular quarterly cash dividend of $0.1825 per share of the Company’s Class A common stock and $0.165 per share of the Company’s Class B common stock. The dividends are payable on February 17, 2026 to stockholders of record as of the close of business on February 3, 2026. About Donegal Group Inc. Donegal Group Inc. is an insurance holding company whose insurance subsidiaries and affilia...
- Pierre FerraguÊ
AMAT APPLIED MATERIALS INC.
DTE DEUTSCHE TELEKOM AG
6758 SONY CORPORATION
00700 TENCENT HOLDINGS LTD.
CSCO CISCO SYSTEMS INC.
AMD ADVANCED MICRO DEVICES INC.
VOD VODAFONE GROUP PLC
9434 SOFTBANK
2357 TT ASUSTEK COMPUTER
981 SEMICONDUCTOR MANUFACTURING
LAZR LUMINAR TECHNOLOGIES INC (A)
GFS GLOBALFOUNDRIES INC
CRWV COREWEAVE INC
Noodles & Company Announces Third Quarter 2025 Financial Results
Noodles & Company Announces Third Quarter 2025 Financial Results BROOMFIELD, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) today announced financial results for its third quarter ended September 30, 2025. Key highlights for the third quarter of 2025 versus the third quarter of 2024 include: Total revenue decreased 0.5% to $122.1 million from $122.8 million in the third quarter of 2024.Comparable restaurant sales increased 4.0% system-wide, comprised of a 4.0% increase at company-owned restaurants and a 4.3% increase at franchise restaurants.Net loss was $9.2 ...
Liquidia Corporation to Present at Upcoming Healthcare Investment Conf...
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’s executive leadership team will be providing updates on the company's business during fireside chats at the following two investor conferences in November: 2025 UBS Global Healthcare Conference on Monday, November 10 beginning at 4:15 p.m. ET in Palm Beach Gardens, F...
Liquidia Corporation Reports Third Quarter 2025 Financial Results and ...
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA salesMore than 2,000 unique patient prescriptions and 1,500 patient starts to dateCompany to host webcast today at 8:30 a.m. ET MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascu...
Donegal Group Inc. Announces Third Quarter and First Nine Months of 20...
Donegal Group Inc. Announces Third Quarter and First Nine Months of 2025 Results MARIETTA, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months of 2025. Significant Items for third quarter of 2025 (all comparisons to third quarter of 2024): Net premiums earned decreased 3.4% to $229.8 millionCombined ratio of 95.9%, compared to 96.4%Net income of $20.1 million, or 55 cents per diluted Class A share, compared to $16.8 million, or 51 cents per diluted Class A shareNet ...
Liquidia Corporation to Report Third Quarter 2025 Financial Results on...
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025 MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The webcast will be available on Liquidia's website at . A rebroadcast of the e...
Donegal Group Inc. Announces Quarterly Dividend
Donegal Group Inc. Announces Quarterly Dividend MARIETTA, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) reported today that its board of directors declared a regular quarterly cash dividend of $0.1825 per share of the Company’s Class A common stock and $0.165 per share of the Company’s Class B common stock. The dividends are payable on November 17, 2025 to stockholders of record as of the close of business on November 3, 2025. About Donegal Group Inc. Donegal Group Inc. is an insurance holding company whose insurance subsidiaries and affilia...
Noodles & Company to Announce Third Quarter 2025 Results on November 5...
Noodles & Company to Announce Third Quarter 2025 Results on November 5, 2025 BROOMFIELD, Colo., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) today announced that it will host a conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 p.m. ET. Joe Christina, Chief Executive Officer, and Mike Hynes, Chief Financial Officer, will host the call. A press release with third quarter 2025 financial results will be issued after the market close that same day. The conference call can be accessed live over the phone by dialing...
Liquidia Corporation to Host R&D Day in New York City on October 28, 2...
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025 MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Development Day (R&D Day) on Tuesday, October 28, 2025, in New York City which will be webcast from 2:00 p.m. to 4:30 p.m. Eastern Standard Time. The event will feature presentations from Liquidia’s management team alongside three key opinion leaders (KOLs) in the treatment...
Donegal Group Inc. Announces Release Date for Third Quarter 2025 Resul...
Donegal Group Inc. Announces Release Date for Third Quarter 2025 Results MARIETTA, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for third quarter ended September 30, 2025, on Thursday, October 30, 2025, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at , concurrently with its earnings press release. At approximately 8:30 am ET on Thursday, October 30, 2025, the Company w...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.